CRISPR Therapeutics AGCRSPNASDAQ
Loading
Gross profit as a percentage of revenue
Percentile
P20
Within normal range
vs 2Y Ago
-132.1x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | -8560.01% | -3881.4% |
| 2024 | -215.00% | -431.8% |
| 2023 | 64.80% | +100.3% |
| 2022 | -25186.70% | -28425.4% |
| 2021 | 88.92% | +100.2% |
| 2020 | -37369.68% | -98277.3% |
| 2019 | 38.06% | +101.1% |
| 2018 | -3541.90% | -4941.4% |
| 2017 | -70.26% | +90.2% |
| 2016 | -717.93% | - |